Poster Session: Bacteremia
Joachim Doua, MD, MPH
Janssen Research & Development, Infectious Diseases & Vaccines, Janssen Pharmaceutica
Beerse, Antwerpen, Belgium
Jesús Rodriguez Baño, MD, PhD
University of Sevilla and Biomedicine Institute of Sevilla
Seville, Andalucia, Spain
Jeroen Geurtsen, PhD
Janssen Vaccines & Prevention BV
Leiden, Zuid-Holland, Netherlands
Oscar Go, PhD
Associate Director
Janssen Research & Development
Raritan, New Jersey, United States
Michal Sarnecki, MD
Medical Leader VX Bern Clin
Janssen Research & Development, Janssen Vaccines
Bern, Bern, Switzerland
Tuba Vilken, PhD
Laboratory of Medical Microbiology, Vaccine & Infectious Disease Institute, University of Antwerp
Antwerp, Antwerpen, Belgium
Bart Spiessens, PhD
Senior Scientific Director Biostatistics
Janssen Research & Development, Infectious Diseases & Vaccines, Janssen Pharmaceutica
Beerse, Antwerpen, Belgium
Christine Vallejo, MD
Emergency Department and Inserm Clinical Investigation Center 1435, Dupuytren University Hospitall
Limoges, Limousin, France
Herman Goossens, MD
Professor
Vaccine & Infectious Disease Institute, University of Antwerp
Antwerp, Antwerpen, Belgium
Marc Bonten, MD, PhD
Julius Center for Health Sciences and Primary Care, University Medical Center
Utrecht, Utrecht, Netherlands
Jan Poolman, PhD
VP Bacterial Vaccines
Bacterial Vaccines Discovery and Early Development, Janssen Vaccines & Prevention B.V.
Leiden, Zuid-Holland, Netherlands
Miquel Ekkelenkamp, MD, PhD
Department of Medical Microbiology, University Medical Center Utrecht
Utrecht, Utrecht, Netherlands